These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 35951419)

  • 1. Constructs derived from the addiction cycle predict alcohol use disorder treatment outcomes and recovery 3 years following treatment.
    Witkiewitz K; Stein ER; Votaw VR; Hallgren KA; Gibson BC; Boness CL; Pearson MR; Maisto SA
    Psychol Addict Behav; 2023 May; 37(3):376-389. PubMed ID: 35951419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal measurement invariance of constructs derived from the addiction cycle.
    Boness CL; Votaw VR; Stein ER; Hallgren KA; Witkiewitz K
    Psychol Addict Behav; 2024 Sep; 38(6):649-655. PubMed ID: 38059947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Addictions Neuroclinical Assessment Negative Emotionality Domain Among Treatment-Seekers with Alcohol Use Disorder: Construct Validity and Measurement Invariance.
    Votaw VR; Pearson MR; Stein E; Witkiewitz K
    Alcohol Clin Exp Res; 2020 Mar; 44(3):679-688. PubMed ID: 31957027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Examining the validity of the addictions neuroclinical assessment domains in a crowdsourced sample of adults with current alcohol use.
    Votaw VR; Boness CL; Stein ER; Watts AL; Sher KJ; Witkiewitz K
    Exp Clin Psychopharmacol; 2024 Feb; 32(1):68-83. PubMed ID: 37227882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validity and measurement invariance of the Addictions Neuroclinical Assessment incentive salience domain among treatment-seekers with alcohol use disorder.
    Stein ER; Votaw VR; Swan JE; Witkiewitz K
    J Subst Abuse Treat; 2021 Mar; 122():108227. PubMed ID: 33509416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns of drinking behavior around a treatment episode for alcohol use disorder: Predictions from pre-treatment measures.
    Witkiewitz K; Kirouac M; Baurley JW; McMahan CS
    Alcohol Clin Exp Res (Hoboken); 2023 Nov; 47(11):2138-2148. PubMed ID: 38226755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neural correlates of alcohol use disorder severity among nontreatment-seeking heavy drinkers: An examination of the incentive salience and negative emotionality domains of the alcohol and addiction research domain criteria.
    Al-Khalil K; Vakamudi K; Witkiewitz K; Claus ED
    Alcohol Clin Exp Res; 2021 Jun; 45(6):1200-1214. PubMed ID: 33864389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurofunctional Domains Derived From Deep Behavioral Phenotyping in Alcohol Use Disorder.
    Kwako LE; Schwandt ML; Ramchandani VA; Diazgranados N; Koob GF; Volkow ND; Blanco C; Goldman D
    Am J Psychiatry; 2019 Sep; 176(9):744-753. PubMed ID: 30606047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of negative emotionality, NIAAA recovery, and 3- and 6-month drinking outcomes among adults in treatment for alcohol use disorder.
    Linn BK; Zhao J; Stasiewicz PR; LaBarre C; Wilding GE; Bradizza CM
    Drug Alcohol Depend; 2023 Jan; 242():109695. PubMed ID: 36442440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alcohol use disorder and sleep disturbances: a feed-forward allostatic framework.
    Koob GF; Colrain IM
    Neuropsychopharmacology; 2020 Jan; 45(1):141-165. PubMed ID: 31234199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the Addictions Neuroclinical Assessment (ANA) framework through deep phenotyping of problem drinkers.
    Nieto SJ; Grodin EN; Green R; Ray LA
    Drug Alcohol Depend; 2021 Apr; 221():108603. PubMed ID: 33618192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors underlying the neurofunctional domains of the Addictions Neuroclinical Assessment assessed by a standardized neurocognitive battery.
    Gunawan T; Luk JW; Schwandt ML; Kwako LE; Vinson T; Horneffer Y; George DT; Koob GF; Ramchandani VA; Diazgranados N; Goldman D
    Transl Psychiatry; 2024 Jul; 14(1):271. PubMed ID: 38956031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compounding Vulnerability in the Neurocircuitry of Addiction: Longitudinal Functional Connectivity Changes in Alcohol Use Disorder.
    Fede SJ; Kisner MA; Manuweera T; Kerich M; Momenan R
    Alcohol Alcohol; 2022 Nov; 57(6):712-721. PubMed ID: 35760068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neural correlates of the addictions neuroclinical assessment (ANA) incentive salience factor among individuals with alcohol use disorder.
    Nieto SJ; Grodin EN; Ray LA
    Behav Brain Res; 2024 Apr; 464():114926. PubMed ID: 38431152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reward and relief craving tendencies in patients with alcohol use disorders: results from the PREDICT study.
    Glöckner-Rist A; Lémenager T; Mann K;
    Addict Behav; 2013 Feb; 38(2):1532-1540. PubMed ID: 23148916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of relative-reinforcement value of alcohol-free activities during recovery from alcohol use disorder in an adult clinical sample.
    Kuhlemeier A; Tucker JA; Witkiewitz K
    Exp Clin Psychopharmacol; 2024 Aug; 32(4):410-417. PubMed ID: 38635163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Applying the Addictions Neuroclinical Assessment to derive neurofunctional domains in individuals who use methamphetamine.
    Nieto SJ; Ray LA
    Behav Brain Res; 2022 Jun; 427():113876. PubMed ID: 35378110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reward and relief dimensions of temptation to drink: construct validity and role in predicting differential benefit from acamprosate and naltrexone.
    Roos CR; Mann K; Witkiewitz K
    Addict Biol; 2017 Nov; 22(6):1528-1539. PubMed ID: 27480445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Addiction resistance to alcohol: What about heavy drinkers who avoid alcohol problems?
    Hoffmeister JR; Cohoon AJ; Sorocco KH; Acheson A; Lovallo WR
    Drug Alcohol Depend; 2019 Nov; 204():107552. PubMed ID: 31539868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contextual decision-making and alcohol use disorder criteria: Delayed reward, delayed loss, and probabilistic reward discounting.
    Acuff SF; Boness CL; McDowell Y; Murphy JG; Sher KJ
    Psychol Addict Behav; 2023 Feb; 37(1):121-131. PubMed ID: 35925727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.